Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: A phase II study

Radiotherapy and Oncology

Volumn 89, Issue 3, 2008, Pages 263-269

  Giralt, Jordi ^a   Tabernero, Josep ^a   Navalpotro, Begoña ^a   Capdevila, Jaume ^a   Espin, Eloi ^a   Casado, Esther ^a   Mañes, Anabel ^a   Landolfi, Stefania ^a   Sanchez Garcia, Jose Luis ^a   de Torres, Ines ^a   Armengol, Manel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Leucovorin; Pre operative treatment; Radiotherapy; Rectal cancer; UFT

Indexed keywords

FOLINIC ACID; UFT;

ADULT; AGED; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; FEMALE; HAND FOOT SYNDROME; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MOUTH INFLAMMATION; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RECTUM BIOPSY; RECTUM CANCER; TUMOR REGRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; RECTAL NEOPLASMS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 56949107725     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.07.010     Document Type: Article

References (35)

1. Camma C., Giunta M., Fiorica F., Pagliaro L., Craxi A., and Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 284 (2000) 1008-1015
2. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-1304.
3. Sauer R., Becker H., Hohenberger W., Rodel C., Wittekind C., Fietkau R., et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
4. Bosset J.F., Collette L., Gilles C., Mineur L., Maingon P., Rodosevic-Jelic L., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
5. Das P., Lin E.H., Bhatia S., Skibber J.M., Rodriguez-Bigas M.A., Feig B.W., et al. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 66 (2006) 1378-1383
6. Crane C.H., Skibber J.M., Birnbaum E.H., Feig B.W., Singh A.K., Delclos M.E., et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57 (2003) 84-89
7. Mehta V.K., Cho C., Ford J.M., et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55 (2003) 132-137
8. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331 (1994) 502-507
9. Puig-la Calle Jr. J., Lopez Sanchez S., Piedrafita Serra E., Allende Honorato L., Artigas Raventos V., and Puig la Calle J. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 62 (1996) 273-278
10. Ho D.H., Pazdur R., Covington W., Brown N., Huo Y.Y., Lassere Y., et al. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil. Clin Cancer Res 4 (1998) 2085-2088
11. Borner M.M., Schoffski P., de Wit R., Caponigro F., Comella G., Sulkes A., et al. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 38 (2002) 349-358
12. Douillard J.Y., Hoff P.M., Skillings J.R., Eisenberg P., Davidson N., Harper P., et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20 (2002) 3605-3616
13. Carmichael J., Popiela T., Radstone D., Falk S., Borner M., Oza A., et al. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20 (2002) 3617-3627
14. Hoff P.M., Janjan N., Saad E.D., Skibber J., Crane C., Lassere Y., et al. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. J Clin Oncol 18 (2000) 3529-3534
15. Feliu J., Calvilio J., Escribano A., de Castro J., Sanchez M.E., Mata A., et al. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 13 (2002) 730-736
16. Vestermark L.W., Jacobsen A., Qvortrup C., Hansen F., Bisgaard C., Baatrup G., et al. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Acta Oncol 47 (2008) 428-433
17. Fernández-Martos C., Aparicio J., Bosch C., Torregrosa M., Campos J.M., Garcera S., et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-up. J Clin Oncol 22 (2004) 3016-3022
18. de la Torre A., García-Berrocal M.I., Arias F., Mariño A., Valcárcel F., Magallón R., et al. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin. Int J Radiat Oncol Biol Phys 70 (2008) 102-110
19. Glimelius B., Isacsson U., Jung B., and Pahlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys 37 (1997) 281-287
20. Gerard J.P., Chapet O., Nemoz C., Hartweig J., Romestaing P., Coquard R., et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol 22 (2004) 2404-2409
21. Ryan R., Gibbons D., Hylan J.M.P., Treanor D., White A., Mulcahi H.E., et al. Pathological response following long- course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 47 (2005) 141-146
22. Bouzourene H., Bosman F.T., Seelentag W., Matter M., and Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94 (2002) 1121-1130
23. Gehan E.A. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis 13 (1961) 1
24. Janjan N.A., Abbruzzese J., Pazdur R., Khoo V.S., Cleary K., Dubrow R., et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol. 51 (1999) 153-160
25. Muthusamy V.R., and Chang K.J. Staging optimal methods for staging rectal cancer. Clin Cancer Res 13 (2007) 6877s-6881s
26. Dunst J., Reese T., Sutter T., Zühlke H., Hinke A., Kölling-Schlebusch K., et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 20 (2002) 3983-3991
27. Souglakos J., Androulakis N., Mavroudis D., Kourousis C., Kakolyris S., Vardakis N., et al. Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. Int J Radiat Oncol Biol Phys 56 (2003) 1284-1287
28. Craven I., Crellin A., Cooper R., Melcher A., Byrne P., and Sebag-Montefiore D. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer 97 (2007) 1333-1337
29. Wiltshire K.L., Ward I.G., Swallow C., Oza A.M., Cummings B., Pond G.R., et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys. 64 (2006) 709-716
30. Mohiuddin M., Regine W.F., John W.J., Hagihara P.F., McGrath P.C., Kenady D.E., et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys. 46 (2000) 883-888
31. Mohiuddin M., Winter K., Mitchell E., Hanna N., Yuen A., Nichols C., et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol. 24 (2006) 650-655
32. Jakobsen A., Mortensen J.P., Bisgaard C., Lindebjerg J., Hansen J.W., and Rafaelsen S.R. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost. Int J Radiat Oncol Biol Phys 64 (2006) 461-465
33. Wong R.K., Tandan V., De Silva S., and Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database System Review 2 (2007) CD002102
34. Collete L., Bosset J.F., den Dulk M., Nguyen F., Mineur L., Maingon P., et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organization for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 25 (2007) 4379-4386
35. Janjan N.A., Crane C., Feig B.W., Cleary K., Dubrow R., Curley S., et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24 (2001) 107-112